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Propositions 
 
Transforming Data into Knowledge for Intelligent 
Decision-making in Early Drug Discovery  
 
1. A screening paradigm involving an iterative expansion around hits using 
biological and chemical similarity metrics in parallel can result in greatly 
improved efficiency over conventional high-throughput screening 
campaigns. 
 
This thesis, Chapter four 
 
2. Descriptors derived from atom topology show a strong correlation with 
fingerprint-based descriptors with respect to diversity assessment of a 
number of compound sets ranging in size, diversity and origin. 
 
This thesis, Chapter three 
 
3. The Bayes Affinity Fingerprints showed the best performance in selecting 
compound sets that are diverse in bioactivity space, compared to twelve 
other commonly used fingerprint-based, pharmacophore-based, shape-
based, connectivity-matrix-based, and physicochemical-property-based 
descriptors. 
 
This thesis, Chapter three 
 
4. The concept of active learning can be used to derive compound sets that, 
once screened and used as training sets for machine learning, predict 
bioactivity of unknown compounds better than when randomly selected 
training sets are used. 
 
This thesis, Chapter five 
 
5. Despite improvements in screening technology, high-throughput 
screening campaigns are still costly due to the large amount of resources 
required in relation to the number of active compounds discovered. 
 
Phatak, S. S., Stephan, C. C., and Cavasotto, C. N. (2009) High-throughput and in silico 
screenings in drug discovery. Expert. Opin. Drug Discov. 4, 947–959. 
 
6. Even though over 1063 drug-like molecules possibly exist, it is likely that 
only a fraction of these molecules is therapeutically relevant. This is 
evidenced by the success of high-throughput screening campaigns 
comprising “only” 106 molecules. 
 
Lipinski, C., Hopkins, A. (2004) Navigating Chemical Space for Biology and Medicine. 
Nature 432, 855–861. 
 
7. Efficient exploration of relevant chemical space is important for targets 
with few known active chemotypes or phenotypic assays. Diversity-based 
library design is aimed at addressing this need by optimizing biological 
relevance and compound diversity to provide multiple starting points for 
further development. 
 
Roth, H. J. (2005) There is no such thing as “diversity”! Curr. Opin. Chem. Biol. 9, 293–295 
 
8. Chemical diversity is an ambiguous concept, as it can be based on a wide 
range of chemical or biological descriptors. 
 
Roth, H. J. (2005) There is no such thing as “diversity”! Curr. Opin. Chem. Biol. 9, 293–295 
 
9. At the strategic level, the game of chess bears resemblance to a PhD: 
competence in the opening (action plan), middlegame (execution), and 
endgame (completion and communication of results) is essential for 
success. 
 
10. Although the personal contribution of a PhD candidate is paramount, the 
overall productivity is highly dependent on effective collaboration with 
the advisors and fellow researchers. From this point of view, an analogy to 
an a cappella choir can be drawn: the vocal support of all artists involved 
makes or breaks the impact of the lead artist. 
 
